Preliminary programme

Please, note that the Conference agenda may still undergo significant changes due to organizational reasons.

OTHER STRATEGIES FOR GENE THERAPY

Chairs: Peter Lenting (France), David Lillicrap (Canada)

9:00-9:20

Lentiviral vector transduced autologous hematopoietic stem cell-based gene therapy for haemophilia A
Alok Srivastava (India)

9:20-9:40

Lentivirus in haemophilia B
Luigi Naldini (Italy)

9:40-10:00

Non-viral strategies for gene therapy
David Lillicrap (Canada)

10:00-10:15

Discussion

10:15-10:45

Coffee break

JOINT AND BONE HEALTH IN HAEMOPHILIAS

Chairs: Roberta Gualtierotti (Italy), Jan Voorberg (The Netherlands)

10:45-11:05

Open questions for joint health
Pratima Chowdary (UK)

11:05-11:25

Artificial intelligence and telemedicine for joint health in haemophilia patients
Roberta Gualtierotti (Italy), Sergio Mascetti (Italy)

11:25-11:45

The role of factor VIII in bone physiology
Raimondo De Cristofaro (Italy)

11:45-12:00

Discussion

SATELLITE LECTURE

12:00-12:30

Sponsored by CSL Behring

12:30-14:00

Lunch

SATELLITE LECTURE

14:00-14:30

Sponsored by Roche

NEW CLINICAL ASPECTS

Chairs: Pier Mannuccio Mannucci (Italy), Mike Makris (UK)

14:30-14:50

The use of antithrombotic drugs in haemophilia
Roger Schutgens (The Netherlands)

14:50-15:10

Prophylaxis in infants with haemophilia A/B using bispecific antibodies
Karin Fijviandraat (The Netherlands)

15:10-15:30

The clinician’s choice: which patient is suitable for which therapy?
Steven Pipe (US)

15:30-15:45

Discussion

15:45-16:10

Coffee break

KEYNOTE LECTURE

16:10-16:30

Von Willebrand factor functions outside haemostasis
James O’Donnell (Ireland)

16:30-17:30

ORAL COMMUNICATIONS

17:30-18:30

E-POSTER SESSION